Clinical outcomes after switch to mTOR inhibitors in kidney transplant recipients

Introduction: mTOR inhibitors Sirolimus and Everolimus are an alternative for inmunosuppression in renal transplant recipients. The aim of the study was to describe the experience of patients with switch to mTOR inhibitors, followed up for more than five years.Materials and methods: Patients with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Revista Colombiana de Nefrología
Hlavní autoři: Liliana Mesa-Ramírez, Juan C. Gómez-Vega, Jessica Pino-Escobar, Lina M Rivera, Eliana Manzi-Tarapues, Juan G. Posada-Chávez, Johanna Schweineberg-López, Carlos E. Durán-Rebolledo, Jorge I. Villegas-Otálora, Oscar J. Serrano-Ardila, Luis A. Caicedo-Rusca
Médium: Artigo
Jazyk:Inglês
Vydáno: Asociación Colombiana de Nefrología e Hipertensión Arterial 2018
Témata:
Medicina
sirolimus
everolimus
immunosuppression
Kidney transplantation
renal insufficiency chronic
On-line přístup:https://www.redalyc.org/articulo.oa?id=560159496003
https://www.redalyc.org/journal/5601/560159496003/
https://www.redalyc.org/journal/5601/560159496003/html/
https://www.redalyc.org/journal/5601/560159496003/560159496003.epub
https://www.redalyc.org/journal/5601/560159496003/movil
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky